versus to and year, XXXX. digits All in market you, the dollars. not forecasted the and project U.S. are FMC global to market, market. U.S. global crop strength of for from will previously forecasts the up markets Shifting in to Thank Andrew. various the the flat single the these the the impacts COVID-XX We prior due are dollar. be now protection be We low
the North the as crops years assumptions American ago, in acreage digits, on row the Canada dry recovery low based that forecast of and in of thought market months we for single after will grow two conditions. three increased We same a
grow and by a faster expect little will before, digits, Eastern but single in driven We the and thought in corn still we in Europe the cereals than low market Europe markets. strength
versus low expect India in our impact to other already be of growth, on China, the FX single-digit seen Asian the will now based market slightly countries, COVID-XX headwinds. and from down we have estimate We addition prior in
growth the weaker rather we in mid-single our by than demand. it forecast now currencies This contract Latin prior significantly, to our view. versus by market is driven as low slight decline expect lower digits for to lowered also American We
to challenges to guidance seven and downside full more our FMC the Moving and slide company COVID-XX on ranges QX the year pandemic of potential is XXXX by headwinds, guidance. earnings and the the outlook. XXXX, full in as FX certain risk range estimates year-over-year incorporate the now adjusted prior of brought widening to a our review XXXX the be to increase per diluted are year which include X% $X.XX benefit earnings suspending, expected in in Andrew to is of company do the any at repurchases not the of indicated. of midpoint. share, share $X.XX Factoring EPS
in $X.XX of growth, billion will range the at of now organic an $X.XX be versus deliver growth. to X% midpoint high We to of is us and the trend X% our single-digit multiyear performance. organic billion, XXXX increase believe portfolio strength revenue continuing of XXXX a to the forecasted above-market allow
to are the share midpoint versus range QX expected the QX $X.XX XXXX. to range forecast be We of now QX is revenue and at $X.XX at at to compared expected COVID-XX $X.XX midpoint billion to be billion related flat which X% believe EBITDA Adjusted challenging uncertain to is year-over-year conditions will $X.XX, second in to to be in billion, represents in range Adjusted most $X.XX of quarter the to the diluted $X.XX XXXX. a We the midpoint. earnings per represent growth and currencies. billion, the of flat the which
headwinds, driven products Western the Adjusted Europe, Latin America be decrease improvement FX expected versus forecasted midpoint EBITDA year in million, is million the to organically, of at is X% world. period. by traction around the $XXX to in representing prior and new range the Excluding X% $XXX significant a increase to an strength revenue the primarily gaining in
with revenue to North Revenue X% in and from Turning expected growth, is benefit expected Asia. to drivers. full and largest eight year America growth volume slide the
total products from the EMEA. contribution with in New coming driving growth, about revenue are X.X% largest
FX With top can be see significant to global the now in currencies, headwind. X% you forecasted shift that line a is
X% were currencies. For reference, only in from a headwind we forecasting February, revenue
with the throughout year. to price of these increases expect However, headwinds offset we most
we're expecting To $XX approximately quickly chain price to in proactive addition pockets currencies. COVID-related and supply headwinds, to of EBITDA, anticipated to of help global measures the implemented mitigate costs, these, Regarding significant impacts we demand cost-saving increases. offset million
to guidance our is price reduce When out guidance. expected still net measures $X.XXX lower million. increases, of and COVID-XX billion our range $XX or including midpoint a currencies, million prior Therefore, could than our of by the EBITDA the $XX COVID-XX cost-saving impacts, EBITDA million with $X current
I should the higher the end measures the headwinds towards pushing cost-saving the second half range, note further of the the that if implement see we impact net we will in year. of
obviously is impact rupee, factor This timing We price by Mexican the full real our movement now driven peso, of outlook. an the foresee versus $XXX important and factor including how critical euro, exchange Indonesian Indian year, recover a we etc. is numerous broad-based in Foreign for Brazilian the for the currencies, million will FX. rupee, an in
is second $XX main million, the of expect an quarter, In XX%. we impact FX price-to-FX elements. or million $XX with by two price gap of This driven recovery
very to harvest. it pricing First by is on and in quarter the of is this and changes the are specifically the fact volumes tend in lack America that and are growers the second relative in Latin the end Brazil. at driven season in of is season Brazil pricing the focusing tail be This historically lower little power the as time, in made
significantly in as at it over the to appropriate to approach do the we looking QX. market part that rather our would be of impacted in Asia. prices increase COVID-XX, be will year And is Second this recover the we not to pricing than time. by latter feel In such, market
America as the and coverage new as another Looking exchange at normal is This to prices in we rates for price is part which Pricing recovery of actions we pricing in year, the in headwind. the change the XX% year in pattern. will recovery a in are of latter season the seeing previously $XXX QX, Asia the approximately discussed. reflect the full element, are of mainly Latin of expected is million cover set FX
have some for around already shutdowns is seen factor also chain our an outlook, world. temporary the as we Supply important
plant have COVID-XX-induced has customers. restrictions. teams and met China now in situations our FMC navigate know, As the over successfully successfully past years. the managing you the we industry in managing been two The active shutdowns helped are us that And of those very same demands
taking may are we approach and see availability. of In demand due that food chain addition, labor dislocations to reduced a pockets we conservative
savings these will focused cost-saving R&D. headwinds. each SG&A and year. implementing help savings in elements, Our The measures cost March, quarter on we realize will early offset two them in and are began We this
hiring. are expenditures frozen and eliminating have We or nonessential all delaying
growth In projects, long-term this not lower the our canceling phasing lines. impact we confidently are R&D, cost-saving we These some fundamentally year to we not of say any temporary. that costs time differently allow are and but in without will company. be these impacting cost of actions can will return Most we will XXXX,
headwind X% FX nine, slide see is the expected discussed quarter, On due the previously. fall you second reason is significant as main the EBITDA to to in
will launches overall in organic product volume Asia revenue in Europe, expect and solid New gains X%. we and to QX, of contribute North America all growth
to this and the for we strategic we this Turning Fluindapyr the our Isagro already to XX. we to control technologies on announced added remaining Please new note, today, fungicide EURXX million. binding deck fungicide didn't portfolio the slide slide from rights geographies offer for acquire for is our to intent expand Earlier updated a morning.
You may coming pipeline. as one active of the about of ingredients recall our first R&D us talking out Fluindapyr
We spectrum in and the have in been for codeveloping the this with several to are this launch and U.S. ingredient broad set fall active spring. next years Paraguay fungicide Isagro
including the believe $XXX American global we Isagro's and sales territories. With estimates European, million in Asian for be now peak will rights, $XXX range the full key of Latin million, to
of one crops row As of including in applications. a range plant the specialty diseases, a targeting rust carboxamide, fungicides, soybean newest to belongs Fluindapyr classes crops, of Asia broad turf and
launch the Paraguay in U.S., in and expect to Fluindapyr XXXX we in XXXX. XXXX, in the Argentina Europe and China Following in launches Brazil and
end of the the by acquisition XXXX. third We expect to of close the quarter
weeds received active Isoflex million. with active addition regions to active a new is We to progressing mixture launch million also strategies. serve intend anticipate herbicide in our $XXX registration winter for our new It now exciting sales a to crop Overwatch for season. by many recently all Isoflex launch of peak segment and pipeline, of from in as to action cereals. the $XXX second herbicide bixlozone, R&D Australia a to launch. grass towards as centerpiece portfolio is active set mode We the full Isoflex herbicide will XXXX, ingredient crop an in and is four in Isoflex of our we offers XXXX Additionally, and and branded
received EPA to formulated in recently control action diamide bifenthrin. superior Rynaxypyr new the U.S., important Finally, we an allows rapid franchise. Elevest our the while of residual upgrade for of the in insecticide growers approval expand product. diamide-based role the play plans to a It insecticide, will keeping
country the receive While launch the we to the all to product expect geographies. in U.S. first registration, is key this
highlight ACC close, the Before annual FMC's is Year and safety health, excellence Responsible recent the would like as third the sustainability. environmental, Chemistry leadership in Company for Care distinction American the Council's since I I highest XXXX. and of time for to This recognition award
While past and remained FMC many undergone sustainably operating years, has our changes steadfast. safely commitment few the over to
turn call I'll to the back Pierre. now